Photo and profile from the clinic’s website: "Arabkir" Joint Medical Center — Institute of Child and Adolescent Health: arabkirmc.am, captured on 15 Sep 2026

Anna Galstyan

Neurosurgeon

Yerevan · Arabkir

No reviews yetLeave a review

Call the clinic

Directly, without intermediaries

Swipe right for more sections →

About the doctor

Specialty: Neurosurgeon
City: Yerevan · Arabkir

Work experience

08/2020 – Present Astghik Medical Center, Yerevan, Armenia, Neurosurgeon | 10/2019 – Present Arabkir Medical Center, Yerevan, Armenia, Neurosurgeon | 02/2013 –11/2014 Arabkir Medical Center, Yerevan, Armenia, Neurosurgeon | 06/2011 –06/2012 City Clinical Hospital N15, Moscow, Russian Federation, Neurosurgeon | 01/2010 –06/2012 City Clinical Hospital N67, Moscow, Russian Federation, Neurosurgeon 1992 –1998 MD (1998) Yerevan State Medical University Named after Mkhitar Heratsi, Armenia | 2003 –2009 PhD (2009) Russian Academy of Medical Science, Burdenko Neurosurgery Institute, Russian Federation Certificate of Neurosurgery. Russian Academy of Postgraduate Education (2020). | License of Practicing in Neurosurgery. Russian Academy of Postgraduate Education (2012). | License of Practicing in Neurosurgery. Russian Academy of Postgraduate Education (2009). | 04/2014 – 07/2014 Neurosurgery International Fellowship granted by WFNS, NYU Langone Medical Center, NY, USA | 04/2003 – 09/2008 Burdenko Neurosurgery Institute, Department of Pediatric Neurosurgery, Moscow, Russian Federation/PhD student (aspirantura) | 10/1998 –09/2001 National Institute of Health, Yerevan, Armenia, Neurosurgery Residency | 07/2018–08/2019 Cedars-Sinai Medical Center, Nanomedicine Center, Neurosurgery Department, Los Angeles, USA, Project Scientist | 11/2014–07/2018 Cedars-Sinai Medical Center, Nanomedicine Center, Neurosurgery Department, Los Angeles, USA, Postdoctoral Research Scientist | 07/2014 Mount Sinai School of Medicine, Dr. Zou Laboratory, NY, USA. Volunteer Researcher | Nano-immunoconjugates delivery to the brain and checkpoint inhibitors for treatment of glioblastoma. | Air pollution and brain tumors. Influence of different kind of particles and exposure time on tumorogenesis, brain inflammation, and degenerative diseases. | New approaches for the treatment of primary and metastatic cancer using checkpoint and molecular inhibitors. | Nanotherapeutics in brain lymphoma treatment. | Nanoconjugates delivery for imaging and treatment of Alzheimer’s disease. | Differential MRI imaging for brain tumor metastases using different molecular targeting nanodrugs. | Image-guided surgery and treatment of gliomas. | 1. Single- and Multi-Arm Gadolinium MRI Contrast Agents for Targeted Imaging of Glioblastoma. Patil R, Galstyan A, Grodzinski ZB, Shatalova ES, Wagner S, Israel LL, Ding H, Black KL, Ljubimova JY, Holler E.Int J Nanomedicine. 2020 May 1;15:3057-3070. | 2. Israel LL, Galstyan A, Holler E, Ljubimova JY. Magnetic iron oxide nanoparticles for imaging, targeting and treatment of primary and metastatic tumors of the brain. J Control Release. 2020 Apr 10;320:45-62. | 3. Galstyan A, Markman JL, Shatalova ES, Chiechi A, Korman AJ, Patil R, Klymyshyn D, Tourtellotte WG, Israel LL, Braubach O, Ljubimov VA, Mashouf LA, Ramesh A, Grodzinski ZB, Penichet ML, Black KL, Holler E, Sun T, Ding H, Ljubimov AV, Ljubimova JY. Blood-brain barrier permeable nano immunocomjugates induce local immune responses for glioma therapy. Nat Commun. 2019 Aug 28;10(1):3850 | 4. Araujo JE, Jorge S, Santos HM, Chiechi A, Galstyan A, Lodeiro C, Diniz M, Kleinman MT, Ljubimova JY, Capelo JL. Proteomic changes driven by urban pollution suggest particulate matter as a deregulator of energy metabolism, mitochondrial activity, and oxidative pathways in the rat brain. Sci Total Environ. 2019 Oct 15;687:839-848 | 5. Patil R, Galstyan A, Sun T, Shatalova ES, Butte P, Mamelak AN, Carico C, Kittle DS, Grodzinski ZB, Chiechi A, Ding H, Black KL, Ljubimova JY, Holler E. Polymalic acid chlorotoxin nanoconjugate for near-infrared fluorescence guided resection of glioblastoma multiforme. Biomaterials. 2019 Jun; 206:146-159 | 6. Sun T, Patil R, Galstyan A, Klymyshyn D, Ding H, Chesnokova A, Cavenee WK, Furnari FB, Ljubimov VA, Shatalova ES, Wagner S, Li D, Mamelak AN, Bannykh SI, Patil CG, Rudnick JD, Hu J, Grodzinski ZB, Rekechenetskiy A, Falahatian V, Lyubimov AV, Chen YL, Leoh LS, Daniels-Wells TR, Penichet ML, Holler E, Ljubimov AV, Black KL, Ljubimova JY. Blockade of a Laminin-411-Notch Axis with CRISPR/Cas9 or a Nanobioconjugate Inhibits Glioblastoma Growth through Tumor-Microenvironment Cross-talk. Cancer Res. 2019 Mar 15;79(6):1239-1251 | 7. Israel LL, Braubach O, Galstyan A, Chiechi A, Shatalova ES, Grodzinski Z, Ding H, Black KL, Ljubimova JY, Holler E.A Combination of Tri-Leucine and Angiopep-2 Drives a Polyanionic Polymalic Acid Nanodrug Platform Across the Blood-Brain Barrier. ACS Nano. 2019 Feb 26; 13(2):1253-1271 | 8. Ljubimova JY, Braubach O, Patil R, Chiechi A, Tang J, Galstyan A, Shatalova ES, Kleinman MT, Black KL, Holler E. Coarse particulate matter (PM2.5-10) in Los Angeles Basin air induces expression of inflammation and cancer biomarkers in rat brains. Sci Rep. 2018 Apr 9;8(1):5708 | 9. Ding H, Fox I, Patil R, Galstyan A, Black KL, Ljubimova JY, and Holler E. “Polymalic acid tritryptophan copolymer interacts with lipid membrane resulting in membrane solubilization”. Journal of Nanomaterials, 2017 | 10. Chou ST, Patil R, Galstyan A, Gangalum PR, Cavenee WK, Furnari FB, Ljubimov VA, Chesnokova A, Kramerov AA, Ding H, Falahatian V, Mashouf L, Fox I, Black KL, Holler E, Ljubimov AV, Ljubimova JY. "Simultaneous blockade of CK2 and EGFR pathways by tumor-targeted nanobioconjugates significantly improves therapeutic efficacy against glioblastoma multiforme”. Journal of Controlled Release, 244 (2016) 14-23. | 11. Ding H, Gangalum PR, Galstyan A, Fox I, Patil R, Hubbard P, Murali R, Ljubimova JY, Holler E. “HER2-positive breast cancer targeting and treatment by a 2 peptide-conjugated mini nanodrug”. Nanomedicine: Nanotechnology, Biology, and Medicine, pii: S1549-9634(16)30103-4. 2016 Aug | 12. Galstyan AG, Melikian AG, Korshunov AE, Arutyunov NV. “Endoscopic ventriculostomy of the third ventricle in infants of less than 2 years of age”. Zh Vopr Neirokhir Im N.N. Burdenko. (1):11-6; discussion 16-7. Russia, Jan-Mar 2008.Show in fullShow less

Education

1998 · DegreeYerevan State Medical University Named after Mkhitar Heratsi. Russian Academy of Medical Science, Burdenko Neurosurgery Institute, PhD studies